Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Archives of Gynecology and Obstetrics
Erschienen in: Archives of Gynecology and Obstetrics 3/2015

01.03.2015 | Gynecologic Endocrinology and Reproductive Medicine

Impact of sperm cell source on the results of intracytoplasmic sperm injection

verfasst von: Christian Gnoth, Vitaly Markhinin, Beatrice Maxrath, Therese Skonieczny, Kerstin Friol, Judith Roos, Gohar Rahimi, Erhard Godehardt

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

There is an ongoing debate whether the source of sperm cells, the etiology or the extent of male factor infertility has influence on the outcome of ICSI cycles.

Methods

The results of intracytoplasmic sperm injection (ICSI) according to the source of spermatozoa in patients with severe male factor infertility were compared in a retrospective study: 249 couples underwent a total of 337 fresh ICSI cycles with the use of fresh motile testicular or fresh motile ejaculated spermatozoa.

Results

For all variables, there were no statistically significant differences in the ICSI results between both groups. Fertilization rates were 46.8 % for testicular and 47.6 % for ejaculated spermatozoa. Live birth rates per embryo transfer were 20.4 % using testicular spermatozoa and 22.8 % using ejaculated spermatozoa.

Conclusions

Neither the source of spermatozoa nor the etiology of severe male infertility has relevant impact on the results of ICSI cycles as long as fresh motile, morphologically normal spermatozoa are used. Therefore, in case of cryptozoospermia, we recommend to preferentially use ejaculated spermatozoa to prevent those men from an unnecessary testicular biopsy avoiding risks and costs implied.
Literatur
1.
Nagy ZP, Liu J, Joris H, Verheyen G, Tournaye H, Camus M, Derde MC, Devroey P, van Steirteghem AC (1995) The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum Reprod 10:1123–1129PubMed
2.
Strassburger D, Friedler S, Raziel A, Schachter M, Kasterstein E, Ron-El R (2000) Very low sperm count affects the result of intracytoplasmic sperm injection. J Assist Reprod Genet 17:431–436PubMedCentralPubMedCrossRef
3.
Tournaye HJ, Cohlen BJ (2012) Management of male-factor infertility. Best Pract Res Clin Obstet Gynaecol 26:769–775PubMedCrossRef
4.
French DB, Sabanegh ES Jr, Goldfarb J, Desai N (2010) Does severe teratozoospermia affect blastocyst formation live birth rate and other clinical outcome parameters in ICSI cycles? Fertil Steril 93:1097–1103PubMedCrossRef
5.
Amirjannati N, Heidari-Vala H, Akhondi MA, Hosseini Jadda SH, Kamali K, Sadeghi MR (2011) Comparison of intracytoplasmic sperm injection outcomes between spermatozoa retrieved from testicular biopsy and from ejaculation in cryptozoospermic men. Andrologia 43:317–320PubMedCrossRef
6.
Ben-Ami I, Raziel A, Strassburger D, Komarovsky D, Ron-El R, Friedler S (2013) Intracytoplasmic sperm injection outcome of ejaculated versus extracted testicular spermatozoa in cryptozoospermic men. Fertil Steril 99:1867–1871PubMedCrossRef
7.
Celikten A, Batioglu S, Gungor AN, Ozdemir E (2013) Intracytoplasmic sperm injection outcomes of obstructive and nonobstructive azoospermic men. Arch Gynecol Obstet 288:683–686PubMedCrossRef
8.
Demir B, Arikan I, Bozdag G, Esinler I, Karakoc SL, Gunalp S (2012) ICSI outcome of patients with severe oligospermia vs non-obstructive azoospermia. Clin Exp Obstet Gynecol 39:141–143PubMed
9.
Hauser R, Bibi G, Yogev L, Carmon A, Azem F, Botchan A, Yavetz H, Klieman SE, Lehavi O, Amit A, Ben-Yosef D (2011) Virtual azoospermia and cryptozoospermia–fresh/frozen testicular or ejaculate sperm for better IVF outcome? J Androl 32:484–490PubMedCrossRef
10.
Hourvitz A, Shulman A, Madjar I, Levron J, Levran D, Mashiach S, Dor J (1998) In vitro fertilization treatment for severe male factor: a comparative study of intracytoplasmic sperm injection with testicular sperm extraction and with spermatozoa from ejaculate. J Assist Reprod Genet 15:386–389PubMedCentralPubMedCrossRef
11.
Madgar I, Hourvitz A, Levron J, Seidman DS, Shulman A, Raviv GG, Levran D, Bider D, Mashiach S, Dor J (1998) Outcome of in vitro fertilization and intracytoplasmic injection of epididymal and testicular sperm extracted from patients with obstructive and nonobstructive azoospermia. Fertil Steril 69:1080–1084PubMedCrossRef
12.
El-Taieb MA, Herwig R, Nada EA, Greilberger J, Marberger M (2009) Oxidative stress and epididymal sperm transport motility and morphological defects. Eur J Obstet Gynecol Reprod Biol 144(Suppl 1):199–203CrossRef
13.
Gharagozloo P, Aitken RJ (2011) The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Hum Reprod 26:1628–1640PubMedCrossRef
14.
Henkel R, Bastiaan HS, Schuller S, Hoppe I, Starker W, Menkveld R (2010) Leucocytes and intrinsic ROS production may be factors compromising sperm chromatin condensation status. Andrologia 42:69–75PubMedCrossRef
15.
Shiva M, Gautam AK, Verma Y, Shivgotra V, Doshi H, Kumar S (2011) Association between sperm quality oxidative stress and seminal antioxidant activity. Clin Biochem 44:319–324PubMedCrossRef
16.
Tremellen K (2008) Oxidative stress and male infertility–a clinical perspective. Hum Reprod Update 14:243–258PubMedCrossRef
17.
Mahfouz R, Sharma R, Thiyagarajan A, Kale V, Gupta S, Sabanegh E, Agarwal A (2010) Semen characteristics and sperm DNA fragmentation in infertile men with low and high levels of seminal reactive oxygen species. Fertil Steril 94:2141–2146PubMedCrossRef
18.
Guyonnet B, Dacheux F, Dacheux JL, Gatti JL (2011) The epididymal transcriptome and proteome provide some insights into new epididymal regulations. J Androl 32:651–664PubMedCrossRef
19.
Kupker W, Al-Hasani S, Johannisson R, Sandmann J, Ludwig M, Jocham D, Diedrich K (2002) The use of cryopreserved mature and immature testicular spermatozoa for intracytoplasmic sperm injection: risks and limitations. Semin Reprod Med 20:25–35PubMedCrossRef
20.
Greco E, Scarselli F, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Franco G, Anniballo N, Mendoza C, Tesarik J (2005) Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod 20:226–230PubMedCrossRef
21.
Negri L, Patrizio P, Albani E, Morenghi E, Benaglia R, Desgro M, Levi Setti PE (2014) ICSI outcome is significantly better with testicular spermatozoa in patients with necrozoospermia: a retrospective study. Gynecol Endocrinol 30:48–52PubMedCrossRef
22.
Koksal IT, Usta M, Orhan I, Abbasoglu S, Kadioglu A (2003) Potential role of reactive oxygen species on testicular pathology associated with infertility. Asian J Androl 5:95–99PubMed
23.
Gnoth C, Maxrath B, Skonieczny T, Friol K, Godehardt E, Tigges J (2011) Final ART success rates: a 10 years survey. Hum Reprod 26:2239–2246PubMedCrossRef
24.
Bendikson KA, Neri QV, Takeuchi T, Toschi M, Schlegel PN, Rosenwaks Z (2008) The outcome of intracytoplasmic sperm injection using occasional spermatozoa in the ejaculate of men with spermatogenic failure. J Urol 180:1060–1064PubMedCrossRef
25.
Cocuzza M, Alvarenga C, Pagani R (2013) The epidemiology and etiology of azoospermia. Clinics (Sao Paulo) 68(Suppl 1):115–126
26.
Esteves SC, Lee W, Benjamin DJ, Seol B, Verza S Jr, Agarwal A (2013) Reproductive potential of men with obstructive azoospermia undergoing percutaneous sperm retrieval and intracytoplasmic sperm injection according to the cause of obstruction. J Urol 189:232–237PubMedCrossRef
27.
Weissman A, Horowitz E, Ravhon A, Nahum H, Golan A, Levran D (2008) Pregnancies and live births following ICSI with testicular spermatozoa after repeated implantation failure using ejaculated spermatozoa. Reprod Biomed Online 17:605–609PubMedCrossRef
Metadaten
Titel
Impact of sperm cell source on the results of intracytoplasmic sperm injection
verfasst von
Christian Gnoth
Vitaly Markhinin
Beatrice Maxrath
Therese Skonieczny
Kerstin Friol
Judith Roos
Gohar Rahimi
Erhard Godehardt
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2015
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3448-5

Weitere Artikel der Ausgabe 3/2015

Archives of Gynecology and Obstetrics 3/2015 Zur Ausgabe

Case Report

Pregnancy in autosomal recessive polycystic kidney disease

Reply

Response to: Impact of luteal phase hysteroscopy and concurrent endometrial biopsy on subsequent IVF cycle outcome

Gynecologic Oncology

Sexuality issues in gynaecological oncology patients: post treatment symptoms and therapeutic options

Gynecologic Endocrinology and Reproductive Medicine

Perception and attitude of pregnant women in a rural community north-west Nigeria to female genital mutilation

Gynecologic Endocrinology and Reproductive Medicine

Time to pregnancy in subfertile women in German gynecological practices: analysis of a representative cohort of more than 60,000 patients

Letter to the Editor

Impact of luteal phase hysteroscopy and concurrent endometrial biopsy on subsequent IVF cycle outcome

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise